Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
about
New developments in the management of moderate-to-severe hemophilia BAspects of prophylactic treatment of hemophiliaComplications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.Multifocal subdural hematomas as the presenting sign of acquired hemophilia A: a case report.Prevalence and risk factors for hypertension in hemophilia.The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.Health technology assessment and haemophilia.Etiologies of intracerebral hematomas.Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review.The current status of prophylactic replacement therapy in children and adults with haemophilia.Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.The impact of clinical practice on the outcome of central venous access devices in children with haemophilia.Gene therapy for immune tolerance induction in hemophilia with inhibitors.Mortality caused by intracranial bleeding in non-severe hemophilia A patients.Efmoroctocog Alfa: A Review in Haemophilia A.Clinical Characteristics and Prognostic Factors in Hemophiliacs with Intracranial Hemorrhage: A Single-Center, Retrospective Experience.The incidence, risk and functional outcomes of intracranial haemorrhage in children with inherited bleeding disorders at one haemophilia center.Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.Low mortality from intracranial haemorrhage in paediatric patients with haemophilia.Prophylaxis in haemophilia should be life-long.Intracranial haemorrhage in von Willebrand disease: a report on six cases.Emergency department visits in children with hemophilia.Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy.Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis.Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy.From treatment to prevention of bleeds: what more evidence do we need?Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule.Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors.Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment.Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.Risk of major comorbidities among workers with hemophilia: A 14-year population-based study.
P2860
Q26751323-AF85DE08-80CF-4B87-8FD1-8EB5820F2336Q28078562-F62F69C3-50E3-4043-A293-C69AE0080B4CQ31140912-52E66FE8-B1A0-483F-B4CE-CC15D8E476DCQ33828423-85319E10-491B-4B07-BFF1-0E0B4551EE7CQ37363589-1BC00307-13BF-406A-B1CD-35B0AEC3CC1CQ37443624-EDACA138-420E-454A-8187-274BCF1486B1Q37984093-89C60B8B-794E-42E1-8F0D-CA99FDB7BBD3Q38007885-32A87436-9808-454A-A8C6-ED3A68B74BEDQ38070822-AF8FAD46-C15B-41E8-82A0-1971B9A87C77Q38394904-D58BE38B-9C23-4E0F-A2C0-A63FEA195922Q38561882-42F468B7-BF10-4886-A343-5ECC6752172FQ38764085-44749A19-46EC-4D7F-9071-F89324F063ECQ38803022-FEF916AE-BAF4-47EB-A258-AF050C16A680Q38856562-7CF24DD4-5509-4101-99DE-4B521CAE15B9Q38917306-63F64B07-A351-4645-BA1E-73ABD19BC751Q38998225-6C03C26A-7AF6-4412-AA14-7389B6135A4CQ40747271-5A063C83-7522-4B18-904F-C41B6DEF7C06Q40854812-CA4A5F52-B3DA-452E-A0BC-D2A1DD3D0AB4Q40902649-4AE2B885-0B6E-4C2C-AA38-0CD7A4A87E24Q42113961-1D536EA1-156F-4F79-8279-E6AC700DC6F8Q43860503-704F3750-5257-4E34-B9A1-C5B7C47531A8Q44618534-C46AC196-F101-49D1-9B28-000CAFD9C96DQ45792321-0358503A-9BE2-4DEC-A84C-9AB5C4D916C7Q45858535-E9BCAFCC-1D37-46BF-A29D-8D42F47ADCEAQ45864589-364EEA9B-5C4A-47F8-BE01-524F10B3197DQ45868153-CA4C802C-A4E8-442D-95A7-55C23D64F8C5Q45869705-F0391C5A-E33F-4B13-A97A-F8D2F8F82374Q45870834-21FD5C8F-48FF-4E91-99E7-4A65EAE7DB15Q45871759-9ED0A5D6-F4A6-4E7F-AE2A-17588E6DFA0EQ45886106-C3AE7CE7-C90B-4425-B7D7-D53F4EA2671AQ47560053-31711DD3-EE93-4EC6-9D59-C18F48EADAA3Q50117876-100D4632-B5CD-4E0D-B4E6-7BFDCA5EED39
P2860
Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Associations between intracran ...... patients in the United States.
@en
Associations between intracran ...... patients in the United States.
@nl
type
label
Associations between intracran ...... patients in the United States.
@en
Associations between intracran ...... patients in the United States.
@nl
prefLabel
Associations between intracran ...... patients in the United States.
@en
Associations between intracran ...... patients in the United States.
@nl
P2093
P1476
Associations between intracran ...... patients in the United States.
@en
P2093
Char Witmer
J Michael Soucie
Leslie Raffini
Rodney Presley
Roshni Kulkarni
P304
P356
10.1111/J.1365-2141.2010.08469.X
P407
P577
2010-11-29T00:00:00Z